Welcome to the 6th Annual CAR-TCR Summit
The comprehensive forum dedicated to the safe, effective and affordable, clinical and commercial development of CAR and TCR based cell therapies in oncology and beyond.
The CAR-TCR Summit returns to Boston as the industry-leading forum with one goal: to engineer a disease-free world. Bringing together over 1000 CAR and TCR experts from pharma, biotech and academia, this unique platform will provide you with unrivaled networking opportunities with senior level drug developers as well as ground-breaking science and solution-led case studies. Delving into the pioneering developments from early discovery through to late-stage commercialization, this is 4 days your team cannot afford to miss!
"An impactful event that is a must-do for anyone working on CAR-TCR therapies."
Expert Scientific Advisory Board
Chief Development Officer & Vice President, Cancer Immunotherapy
Vice President of Translation
Kite, a Gilead Company
Chief Executive Officer
Chief Medical Officer
Founding Director, Clinical Cell, Vaccine Production Facility
University of Pennsylvania